.1) Trials rarely allow modifying the dose size - so as to compensate for
age (weight of child)
health problems - especially those that consume Vitamin D
pre-existing deficiency
gut problems
poor Vitamin D genes ( many are not noticed by the Vitamin D test)
no gallbladder
use of drugs such as statins
smoking,
2) Trials often do not last long enough
About 1/3 of the trials that I read would have had a benefit if they had only lasted longer
but to minimize trial costs, trials are kept short
3) Trials essentially must be monotherapy -no cofactors such as Magnesium permitted
Meta-analyses rarely consider trials with co-factors, so if a researcher wants his data to be used he does not use cofactors 1
4) Many trials use too small a dose to possibly make a difference
Have seen many trials just using 1,000 IU
One trial used just 200 IU - and did not find a difference!!
Imagine a trial using 1/20 a dose of Aspirin - it would be very unlikely to find any benefit
5) RCTs typically require a placebo group, but many researchers now find it unethical to not give vitamin D to all participants
so their trial is not an RCT - note that an increasing Percentage of the Vitamin D proofs are not RCT
6) Some RCTs are now terminated because
Researchers found too much pain/suffering in those getting the placebo (unethical to give placebo)
Examples: 1, 2, 3,
Too many participants getting the placebo dropped out as they noticed the other group feeling much better and having fewer health problems
7) Some countries (about 30%) consider a mere 20 nanograms to be sufficient for all health problems
When they compare those with < 20 nanograms to those with > 20 nanograms they do not see any benefit
Occasionally, they include charts of the data, in which the benefits of vitamin D can be seen at 30 or 40 nanograms
8) RCTs ignore gene differences that reduce Vitamin D getting to the cells
There is at least a 3 times increased risk for 12 diseases for people having just a Vitamin D Receptor problem
Note: There are 5 additional important Vitamin D genes
9) RCTs sometimes use long times between doses
> 3-week dosing interval provides less benefit
> 6-month dosing intervals can result in problems (negative benefits)
10) RCT researchers are occasionally rewarded for NOT finding a benefit
Example; Professor who concluded that vitamin D (800 IU) does not help bones got 324,000 dollar prize- Nov 2015
11) RCTs rarely use loading doses to restore vitamin D levels in a week or so
Without loading doses many people will fail to show a benefit/get repleted within the typical short RCT length
12) Some RCTs mistakenly continue to use Vitamin D2
D2 is significantly less effective the D3 - especially for non-daily doses
Sometimes D2 actually reduces the level of D3
Over a decade ago Vets decided that Vitamin D2 should not be used on ANY mammal
guess we have to remind doctors that humans are mammals too
13) Some RCT's give Vitamin D when many participants already have enough
14) All participants were allowed to take some vitamin D
Many elderly now take 800 IU of vitamin D - which is 40% of 2,000 IU
15) RCT was given in an area with low Magnesium in water
Too little Magnesium in groundwater
Too much Magnesium and Calcium in groundwater - so water is deharded by provider or by household
Water is desalinated (17,000 desalination plants, 5% of all water consumed)
Water was passed thru a de-osmosis filter
16) Some people decided to not participate in trial because of a health problem
RCT particiants probably are healthier than general population
still have gallbladder, not have gut problems, have higher vitamin D levels, etc.
17) Trial used too low of a Vitamin D threshold (typically 30 ng)
up to 150 ng may be needed
Will notice little benefit if a disease needs 50 ng, but trial had a goal of only 30 ng
18) Trial used vitamin D measurements from a variety of testers
See also Vitamin D Life
- Vitamin D Random Controlled Trials are becoming impossible
- More than 16 reasons why Vitamin D trials fail – Oct 2020
- Vitamin D and RCTs (Randomized Controlled Trials)
- Intervention - Vitamin D has
842 studies - more than half of which are NOT RCT - Several more Vitamin D analyses fail to consider dose size, duration, etc. – Dec 2013
- Is it ethical to NOT give vitamin D in osteoporosis trials– NEJM Sept 2010 many years ago!
- National Osteoporosis Society of UK declares that 12 ng of vitamin D is enough – June 2013
- Example of the many ways that researchers are rewarded for showing that (a tiny amount) of vitamin D does not provide a benefit
- Clinical Trials of vitamin D can have “biological flaws” – Jan 2015
- Even if many RCT show benefits AND many subsequent (meta-analyses conclude that there is a benefit, the doctors often ignore them
- Example: Colorectal cancer 40 percent less likely if 1000 IU more Vitamin D – 21st meta-analysis – Oct 2021
- Example: Vitamin D and fractures – 24 meta-analyses and counting – Dec 2014
17 of the reasons that Vitamin D trials fail45 visitors, last modified 10 Sep, 2025,